About 3F Therapeutics
3F Therapeutics is a company based in Lake Forest (United States) founded in 1998 was acquired by ATS Medical in October 2006.. 3F Therapeutics has raised $23.2 million across 3 funding rounds from investors including Boston Scientific, ATS Medical and Domain Associates. 3F Therapeutics operates in a competitive market with competitors including Endologix, Trivascular, Endoron Medical, Shanghai MicroPort Endovascular MedTech and Aptus Endosystems, among others.
- Headquarter Lake Forest, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$23.2 M (USD)
in 3 rounds
-
Latest Funding Round
$6 M (USD), Series C
Apr 25, 2005
-
Investors
Boston Scientific
& 2 more
-
Employee Count
Employee Count
-
Acquired by
ATS Medical
(Oct 02, 2006)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of 3F Therapeutics
3F Therapeutics has successfully raised a total of $23.2M across 3 strategic funding rounds. The most recent funding activity was a Series C round of $6 million completed in April 2005. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series C — $6.0M
-
First Round
First Round
(11 Apr 2003)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2005 | Amount | Series C - 3F Therapeutics | Valuation |
investors |
|
| Aug, 2004 | Amount | Series B - 3F Therapeutics | Valuation | Boston Scientific | |
| Apr, 2003 | Amount | Series A - 3F Therapeutics | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in 3F Therapeutics
3F Therapeutics has secured backing from 3 investors, including institutional and venture fund investors. Prominent investors backing the company include Boston Scientific, ATS Medical and Domain Associates. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life science & tech focused VC firm investing in the US
|
Founded Year | Domain | Location | |
|
Wide range of medical devices
|
Founded Year | Domain | Location | |
|
Devices for valvular heart disease and arrhythmias are manufactured.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by 3F Therapeutics
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - 3F Therapeutics
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
3F Therapeutics Comparisons
Competitors of 3F Therapeutics
3F Therapeutics operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Endologix, Trivascular, Endoron Medical, Shanghai MicroPort Endovascular MedTech and Aptus Endosystems, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Minimally invasive treatments for aortic disorders are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
Designs and manufactures for endovascular aortic repair equipment
|
|
| domain | founded_year | HQ Location |
Endovascular fixation devices for cardiovascular stent grafts are manufactured.
|
|
| domain | founded_year | HQ Location |
Medical devices for treating aortic diseases are developed.
|
|
| domain | founded_year | HQ Location |
Endograft anchoring systems for aortic aneurysms are developed.
|
|
| domain | founded_year | HQ Location |
Endovascular devices for aortic aneurysms are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about 3F Therapeutics
When was 3F Therapeutics founded?
3F Therapeutics was founded in 1998 and raised its 1st funding round 5 years after it was founded.
Where is 3F Therapeutics located?
3F Therapeutics is headquartered in Lake Forest, United States. It is registered at Lake Forest, California, United States.
Is 3F Therapeutics a funded company?
3F Therapeutics is a funded company, having raised a total of $23.2M across 3 funding rounds to date. The company's 1st funding round was a Series A of $3M, raised on Apr 11, 2003.
What does 3F Therapeutics do?
3F Therapeutics, a part of Medtronic, is a developer of aortic and mitral valve replacement cardiovascular devices in the United States. The device Aortic Bioprosthesis is a biological replacement aortic heart valve to maintain flow characteristics after implant. The company also developed an invasive and transapical aortic heart replacement technology and devices, including an Enable aortic heart valve, an Entrata aortic valve system, and an Endurance valve system to reduce surgical cross-clamp and cardiopulmonary bypass time utilization for congestive heart failures in patients with right heart failure symptoms, and to replicate the natural mitral apparatus. The company holds more than 130 patents focused on a tubular valve concept which enables minimally invasive surgery to repair or replace heart valves. The company was acquired by ATS Medical in 2006, which was in turn acquired by Medtronic.
Who are the top competitors of 3F Therapeutics?
3F Therapeutics's top competitors include Endologix, Trivascular and Shanghai MicroPort Endovascular MedTech.
Who are 3F Therapeutics's investors?
3F Therapeutics has 3 investors. Key investors include Boston Scientific, ATS Medical, and Domain Associates.